ASTRAZENECA

Related by string. AstraZeneca * * AstraZeneca Plc AZN LN . AstraZeneca PLC AZN . Astrazeneca Plc AZN . AstraZeneca Plc AZN . AstraZeneca AZN . AstraZeneca Plc Crestor . AstraZeneca Seroquel XR . AstraZeneca PLC Nexium . AstraZeneca PLC Crestor . AstraZeneca Crestor . AstraZeneca PLC Eli Lilly . AstraZeneca Plc AZN.L Quote . AstraZeneca Seroquel . Bloomberg AstraZeneca Plc *

Related by context. All words. (Click for frequent words.) 83 GLAXOSMITHKLINE 77 NOVARTIS 76 PHARMACEUTICALS 74 PFIZER 72 GLAXO 72 AVENTIS 72 SHARES FALL 71 SANOFI 70 PHARMACEUTICAL 70 TAKEOVER BID 70 TIE UP 70 FDA APPROVES 70 INDICATION 70 LIFE SCIENCES 69 ABBOTT LABORATORIES 69 THERAPEUTICS 69 APPROVAL FOR 69 GROUP LTD 69 PHARMACIES 69 SHARES UP 69 CEPHALON 69 PCT AFTER 69 THOMAS COOK 68 DEUTSCHE BANK 68 PHARM 68 WYETH 68 £ #BN 68 AstraZeneca Plc AZN LN 68 ORD #P 68 IN TALKS WITH 68 SUBMITS 68 LONDON STOCK EXCHANGE 68 SHARES RISE 68 PHASE III 67 GENZYME 67 COMUNICADO DE 67 RESULTS WILL BE 67 INTEREST FROM 67 PHARMA 67 DOWN AFTER 67 POLYMERS 67 BOOST TO 67 SANOFI AVENTIS 67 CRXL 67 WEEK LOW 67 BIOTECHNOLOGY 67 WHAT DOES THE 67 MOVE DOWN 67 SHARES IN 67 DUTY TO 67 GENENTECH 67 SYNGENTA 67 ROW OVER 67 TKPHF 67 SHPGY 66 PSDV 66 TO TAKE OVER 66 IS PLANNING 66 BIOGEN IDEC 66 Pound Keywords 66 OFFER FOR 66 PLUNGES 66 EASES 66 SHARES GAIN 66 SHARES DROP 66 IN TALKS 66 STOCK RISES 66 TRIAL OF 66 HIGHER ON 66 TRENDS IN 66 MLN IN 66 UPTREND CALL REALIZED AS 66 AHOLD 66 AFTER LOSS 66 SURGE IN 66 CLINICAL DATA 66 PROFITS DOWN 66 GlaxoSmithKline plc GSK 66 FEARS OVER 66 SELL OFF 66 IMPROVEMENT OF 66 TO SELL ITS 66 ON DEBUT 66 RISES ON 66 PFIZER INC. 66 AFTER GAINING #.# 66 RIGHTS TO 66 H1 PROFIT 66 GROUP THE TREND 66 UNVEIL 66 PUBLISHES 66 DISAPPOINTED WITH 66 NATIONAL GRID 66 SCHERING PLOUGH 66 RISE IN 66 UP AFTER 66 INTO THE RED 65 INC. REPORTS 65 TAKEOVER OF 65 INVESTMENT BANK 65 SHARE PRICE 65 KV.A 65 APPOINTS NEW 65 FURY OVER 65 AGI Therapeutics 65 TREATMENT OF 65 BIOPHARMA 65 FORECAST * 65 LSE AZN 65 PARMALAT 65 MARZANO 65 PREPARES TO 65 ANNOUNCES APPOINTMENT OF 65 HOLDERS OF 65 DEUTSCHE BANK AG 65 SCIENTIFIC GAMES 65 ;) Keywords 65 COURT RULES 65 TALKS OVER 65 REPORTED IN 65 SCANDAL OF 65 DOWNGRADE ALERT WATCH FOR 65 DAIICHI 65 SHARES SLIDING LOWER DOWN 65 HOLDINGS LTD 65 CONCERN OVER 65 'S QUARTERLY RESULTS 65 FURY AS 65 CADBURY SCHWEPPES 65 HOT STOCK 65 MANAGEMENT INC. 65 REGISTERS 65 ENDO PHARMACEUTICALS 65 Keywords CHINA 65 PROBE INTO 65 ILLEGAL MIGRANTS 65 MERGER WITH 65 NEW DRUG 65 Status Bidding 65 INTESA SANPAOLO 65 IN PATIENTS WITH 65 Amicus Therapeutics NASDAQ 65 IN TALKS OVER 65 FOLLOWING LAST YEAR 65 HUMAN GENOME SCIENCES 65 BOSTON SCIENTIFIC 65 COLLABORATION WITH 65 RALLY TO 65 NEWSLETTERS 65 PACT WITH 65 INFOSYS TECHNOLOGIES 65 £ #.#BN 65 FRIENDS PROVIDENT 65 RELIANCE INDUSTRIES 65 CAPITAL INCREASE 65 COVIDIEN 65 BENEFITS FROM 65 ELI LILLY 65 REPORTS RESULTS 65 MILLION EUROS 65 Novartis AG NOVN VX 64 HEALTHCARE SERVICES 64 ACCENTURE 64 BOOSTS 64 TAKEOVER TALKS 64 TO STUDY 64 HOLDING IN 64 Teva Pharm 64 UP AGAIN 64 £ 1BN 64 'S BIGGEST 64 OBTAINS 64 EPS GROWTH IN 64 ROYAL DUTCH SHELL 64 HAS RISEN 64 Javelin Pharmaceuticals Inc 64 WARNING ON 64 ENTERS INTO 64 DEUTSCHE TELEKOM 64 ALERT FOR 64 INC SAID IT 64 STANDARD CHARTERED 64 STRENGTHENS ITS 64 HORMONE 64 THE HUMAN RESOURCE 64 APPOINTED AS 64 IDIX 64 CONTINUES HIGHER 64 CELGENE 64 CAPITAL OF 64 CORPORATION ANNOUNCES 64 FIRST TIME BUYERS 64 MILLION EURO 64 SINKS 64 TO FUND 64 CONTINUED TO 64 DISTRIBUTION AGREEMENT WITH 64 IS SET TO 64 COUNCIL TAX 64 ON SHARES 64 WORKS WITH 64 RISES TO 64 TO SHED 64 COMPLETES ACQUISITION OF 64 STATUS FOR 64 NET PROFITS 64 ANGER OVER 64 EUROPE STOCKS 64 ON COURSE FOR 64 SINGLES CHART 64 SkyePharma Plc 64 INCREASE OF 64 EXPECTED IN 64 PRODUCTION IN 64 ORD SHS 64 CONCERNS ABOUT 64 BACKING FOR 64 HEINEKEN 64 ALLERGAN 64 VEDANTA 64 THE TREND CONTINUES DOWN 64 INVESTS 64 HUMAN RIGHTS VIOLATIONS 64 'S FAVOURITE 64 OFFERING OF 64 MINING PLC 64 CANCER DRUG 64 INTERNATIONAL LTD 64 TARGET FOR 64 FATE OF 64 WILL BUY 64 BOW TO 64 BIDS FOR 64 LUNG CANCER 64 PENNY STOCK ON 64 Shire SHP.L 64 MOVE FOR 64 CONTINUES UP 64 THE VALUE OF 64 TUMBLES 64 FINANCE DIRECTOR 64 DOWNTREND CALL STOCK PRICE 64 Akorn Inc 64 BOOST FOR 64 AstraZeneca LSE 64 REACH AGREEMENT 64 TO ACQUIRE 64 CRUCELL 64 BIOSCIENCES 64 ON STRONG 64 JPMORGAN 64 UNLIKELY TO 64 REST OF 64 STOCK RISES #.# 64 SWINGS TO 64 EXPRESS SCRIPTS 64 DEAL TO BUY 64 PRICE HIKE 64 AFTER RAISING 64 EARNINGS PREVIEW 'S QUARTERLY 64 TUAM 64 WARNS AGAINST 64 FEARS OF 64 Euro Keywords 64 IS FACING 64 Chuck Mikolajczak cm 64 TRADING IN 64 ZACKS 64 Progenics Pharmaceuticals Inc 64 MEDICINES 64 PLEDGES TO 64 DEAL FOR 64 MERCK 64 PENSION FUND 64 DAY PATTERN FOR 64 TO PROCEED WITH 64 DIAGNOSTICS 64 TO TACKLE 64 ANGER AT 64 EUROPEAN MARKETS 64 PROGRESS ON 64 JOB LOSSES 63 Glaxo GSK 63 Onyx Pharmaceuticals Inc 63 REAFFIRMS 63 LEHMAN BROTHERS 63 PXSL 63 STOCK TO WATCH 63 BEAR STEARNS 63 ANGLO AMERICAN 63 BOOSTED BY 63 PLC ORD #.#P [001] 63 FOR SURVIVAL 63 PRUDENTIAL 63 CAPITAL MARKET 63 SIGNS ON 63 GENERAL ELECTRIC 63 DETECTS POSSIBLE BEARISH INSIDE 63 CONTRACT WITH 63 APPEAL TO 63 MAINTAINS 63 ROG.VX 63 INTERNATIONAL THE TREND 63 STORM OVER 63 RIGHTS ISSUE 63 ANALYST VIEWS 63 AstraZeneca AZN 63 REQUIRED FOR 63 GSK.L 63 CONFIDENT OVER 63 CALLS FOR MORE 63 FINES FOR 63 DEUTSCHE 63 MUST PAY 63 FALLS THRU 63 THE RUN DOWN 63 EARNSHAW 63 ARE YOU CONCERNED ABOUT 63 SENIOR BUSINESS 63 MEDTRONIC 63 PIETERSEN 63 ASSURANCE 63 Shire SHPGY 63 NYSE NVS 63 SAVED BY 63 APPROVALS 63 PAYOUTS 63 EXPLORES 63 WARMER AIR 63 TALKS ON 63 THE TREND CONTINUES LOWER 63 TENDER OFFER 63 COMPANY LTD 63 NET PROFIT UP 63 GROUP HAS 63 ANGLOGOLD 63 SIZE OF 63 SHP.L 63 'S LEADING 63 SET TO BE 63 BRITISH SKY BROADCASTING 63 SHUTS 63 QUALITY SYSTEMS 63 TO SUSPEND 63 THE WINNING STREAK 63 OFFER TO 63 THREATS TO 63 BID TO 63 OPTIMISTIC ABOUT 63 LLOYDS 63 ACCUSED OVER 63 LAUNCHES IN 63 REGAIN 63 RESHUFFLE 63 Merck MRK.N 63 GREEN LIGHT FOR 63 PROFITS UP 63 QUARTER FISCAL 63 CURBS 63 REPORTS STRONG 63 AZN.L 63 ANNOUNCES COMPLETION OF 63 DRRX 63 Lifecycle Pharma 63 NORTH SEA 63 COVERAGE OF 63 HOLDINGS PLC ORD 63 AUXL 63 PRIZE FOR 63 Schering SHR 63 TO LAUNCH NEW 63 PROFIT UP 63 HONEYWELL 63 BAYER 63 ALL OUR 63 DETECTS POSSIBLE BULLISH INSIDE 63 SETS OUT 63 NATIONAL EXPRESS 63 ASSOCIATION WITH 63 CASINI 63 MANDELSON 63 IMPERIAL TOBACCO 63 TOO GOOD FOR 63 HSBC HOLDINGS 63 TO APPEAL 63 DECLINE IN 63 INTEREST IN 63 REVISES 63 Vectura Group 63 FORTHCOMING 63 ARYX 63 DOWNWARD MOMENTUM LOOKS TO 63 INTERIM RESULTS FOR 63 ANNOUNCES SECOND 63 STOCK MARKETS 63 WORLDWIDE INC. 63 SAID TO BE 63 Glaxosmithkline 63 GOVT TO 63 TISSUE 63 READY TO FACE 63 TO INVEST 63 EXPANDS ITS 63 INGELHEIM 63 DEMAND FOR 63 GILEAD SCIENCES 63 Antisoma plc 63 BUYOUT 63 MACQUARIE GROUP 63 DE ATIVIDADE PALAVRA-CHAVE/EMPRESA 63 'S RATING CHANGE 63 MEAN FOR 63 WEEK LOW SET 63 RISE ABOVE 63 RECORDATI 63 PROMOTION PUSH 63 SAID ITS 63 ESTIMATE FOR 63 SHOPPING CENTRE 63 TO REJECT 63 UNDER PRESSURE DOWN 63 MAY FACE 63 IS OUT OF 63 ITS QUARTERLY RESULTS 63 APPROVED BY 63 OF OUR OWN 63 LEVEL OF CASH 63 Keywords CITIGROUP 63 OMISSIONS 63 RAP FOR 63 % TECHNICAL UPTREND 63 REVENUE UP 63 WARNING OVER 63 CALDEROLI 63 TENDER OFFER FOR 63 TEAMS UP WITH 63 OFFERS TO BUY 63 SERVICES INC 63 BIG MOVE 63 AGREED TO 63 CHANCE OF 63 ADDS TO 63 NEWS CORP. 63 AMENDMENT TO 63 SHARES CREEPING HIGHER UP 63 SHARES DOWN 63 BACKED BY 63 THIS CAME AS 63 DECREASE IN 63 CRME 63 UNILEVER 63 PROFIT RISES 63 Regeneron Pharmaceuticals REGN 63 GUARDIOLA 63 DEVELOPMENTS 63 Astrazeneca 63 SIGNS FOR 63 LEVEL IN SHARES 63 AGREEMENT WITH 63 RESTRUCTURE 63 TO DECIDE ON 63 SLIGHTLY HIGHER 63 GOES PROFITABLE THIS YEAR 63 PLASTIC SURGERY 62 HALF YEAR 62 MOVES INTO NEW 62 CHALLENGE FOR 62 SAME AS 62 STRENGTHENS 62 Nasdaq SHPGY 62 UNFAZED BY 62 # DEBTORS MOTION TO 62 Auxilium Pharmaceuticals Inc 62 CARE HOME 62 POISED TO 62 PHARMACEUTICALS LIMITED 62 WITHDRAW FROM 62 TO FORM 62 COULD HIT 62 EXPANSION OF 62 CONTINUES DOWN 62 INVESTMENT GROUP 62 ENTERS NEW 62 'S LARGEST 62 PAY RISE 62 ON TRACK FOR 62 NVGN 62 THOMSON REUTERS 62 IN POSSESSION OF 62 PROGRAMME FOR 62 DEPT OF 62 BROKERAGE 62 LITTLE CHANGE IN 62 DELISTING 62 SATISFIED WITH 62 CREDIT AGRICOLE 62 FREEZES 62 Inspire Pharma 62 INITIATE 62 DISAPPOINT 62 BECKONS FOR 62 FIRM 'S 62 ONXX 62 REINSURANCE 62 PROMPTS 62 WORRY FOR 62 IS CLOSE TO 62 BIDDING FOR 62 CALL ON 62 FOREIGN INVESTMENT REVIEW BOARD 62 MORNING AFTER PILL 62 LLOYDS BANKING GROUP 62 PROFITS FROM 62 WARNS ON 62 UNDERWRITERS 62 JUMPS ON 62 PULLS OUT OF 62 SOUNESS 62 BRISTOL MYERS SQUIBB 62 Keywords SWEDEN 62 SMALL CAP 62 IS CONSIDERING 62 THE TRADING COMPANIES 62 WILLIAMS SISTERS 62 Mylan Labs MYL 62 'S LOSSES 62 STAKE TO 62 AWAY DAY 62 WEEK RECORD LOW 62 IS HOLDING 62 BPAX 62 MERGER OF 62 FOR WORLD CUP 62 LSE SHP 62 REPORTS SECOND QUARTER 62 WILL NOT AFFECT 62 Shire Plc 62 HEADING BACK TO 62 SANTANDER 62 SMARTREND 'S OPTION SCANNER 62 SLAIN IN 62 REVENGE FOR 62 HOUSE PRICE 62 TO BID 62 RESILIENT 62 CALL OFF 62 Warner Chilcott WCRX 62 HALTS 62 PRODUCES 62 FINED OVER 62 'S RALLY 62 BID FOR 62 OPTR 62 CREDIT SUISSE 62 ANNUAL RESULTS 62 CHIEF 'S 62 DIAGNOSTIC 62 PRIVATE EQUITY 62 INCREASED BY 62 GROUP HOLDINGS 62 Biocompatibles International 62 LE GUEN 62 TO PUT UP 62 DRUGS IN 62 DVAX 62 DIRECTORATE 62 RIGHT TO CHANGE 62 EXPANDS TO 62 WILL MEET 62 PLEA TO 62 Eurand NV EURX 62 SHUNS 62 RESUMES 62 NEXT SUPPORT LEVEL FOR 62 SAY ON 62 SENIOR ECONOMIST 62 CARDIOVASCULAR 62 ABIO 62 ARE LOOKING 62 FALL ON 62 POISED FOR 62 CORP BHD 62 STORACE 62 INVESTORS ARE 62 DOWNTREND SPOTTED IN SHARES 62 CELL THERAPEUTICS 62 LIFE TECHNOLOGIES 62 HARVEY NORMAN 62 LISTING OF 62 SIDE EFFECTS CHEAP ONLINE 62 COVERAGE FOR 62 METALS LTD 62 THE CHAMPIONS LEAGUE 62 OPTIONS FOR 62 INDUSTRIES LTD 62 ROUTE TO 62 TO SINK 62 Napo Pharmaceuticals 62 FINANCIAL SECTOR 62 DOWNGRADED ONE WEEK AGO 62 AS POSITIVE EARNINGS 62 KGAA 62 CHAOS AS 62 QUESTIONS ON 62 SHERWIN WILLIAMS 62 WRAPS UP 62 TRADING ON 62 Astrazeneca Plc 62 Plc SHP LN 62 AGREEMENT FOR 62 AGONY FOR 62 EARNINGS REVIEW 62 FLU VACCINE 62 REITERATES 62 Keryx Biopharma 62 STEEL INDUSTRY 62 DETECTED FOR SHARES 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 MANAGEMENT CHANGES 62 BANCA 62 BETTING ODDS 62 SUPPORT FROM 62 LOOMS FOR 62 SET TO PULLBACK AFTER 62 TRADING RANGE ABOVE 62 WEEKLY SESSION 62 CO INC 62 STAKE IN 62 HINTS AT 62 PROCEDURE FOR 62 BHARTI AIRTEL 62 THREAT TO 62 Theravance THRX 62 INSURER 62 CANCELLATION OF 62 AIMING TO 62 Nymox Pharmaceutical 62 REPORTS RECORD 62 DELAY IN 62 MULLS 62 TO POSSIBLY 62 NASDAQ WCRX 62 BANCO SANTANDER 62 DEEPENS 62 ORDER FOR 62 HAS AGREED 62 GAINS ON 62 CURBISHLEY 62 HIKE IN 62 JOB CUTS 62 PRESENTATION AT 62 Regeneron Pharma 62 VICTORY FOR 62 OIL PRICE 62 REPAY 62 MITSUI 62 SHARE SALE 62 CHELSEA MOVE 62 NUMBERS FOR 62 BOURSE 62 CHIEF EXECUTIVE OF 62 UPGRADE ALERT WATCH FOR 62 CONSTELLATION BRANDS 62 SQUAD FOR 62 PRESIDENT MEETS 62 WILL ISSUE 62 RECORD NUMBER OF 62 HAS BEGUN 62 PRICE TARGET 62 SET TO REBOUND AFTER 62 COULD LEAD TO 62 SODIUM 62 ACHIEVES 62 DETECTS BULLISH HARAMI PATTERN 62 MINERALS LTD 62 SUCCESS FOR 62 RISE AGAIN 62 HYPERTENSION 62 TO MERGE 62 DAEWOO SHIPBUILDING 62 TO SUPPLY 62 MASCHERANO 62 SHARE REPURCHASE 62 SPEAKS ON 62 SEE OFF 62 FOR GUNNERS 62 SHRUGS OFF 62 RISE TO 62 SMARTREND RESEARCH REPORT AVAILABLE 62 AstraZeneca Plc AZN 62 SPLIT OVER 62 LOSSES IN 62 ACQUIRING 62 SPECIFIED 62 FLIES TO 62 TO HALT 62 SEIZED IN 61 MOMENTUM LOOKS TO CONTINUE 61 INVESTING IN 61 NOT INTERESTED IN 61 TO REVIVE 61 THE TREND CONTINUES UP 61 Shire plc SHPGY 61 PHARMACEUTICALS INC. 61 SOCIETE GENERALE 61 LICENSED TO 61 CLOCKWATCH 61 IN FAVOUR OF 61 TO LIMIT 61 AXA ASIA PACIFIC 61 PROVIDES UPDATE ON 61 COURT UPHOLDS 61 SHAMBLES 61 BENETTON 61 INVESTMENT FUND 61 CURLE 61 PERCENT AFTER 61 SHOCK FOR 61 DOWN FROM 61 INDUSTRIALS 61 SAME AGAIN FOR 61 REPURCHASE OF 61 BILL FOR 61 BRACED FOR 61 CORP. ANNOUNCES 61 COMMENCE 61 Seattle Genetics SGEN 61 MLNM 61 HAPPY AT 61 ISSUES WARNING 61 TO BOOST 61 SNAP UP 61 SALES DIRECTOR 61 ADDITION OF 61 HOLDRS TRUST 61 HARTSON 61 ON BRINK OF 61 TO MERGE WITH 61 GOVERNMENT OFFICIALS 61 TRANSFER TALK 61 #MG CAP [002] 61 Onyx Pharmaceuticals ONXX 61 PROFIT WARNING 61 HAVE TURNED 61 STAINLESS STEEL 61 CANCER TREATMENT 61 ON FOREIGN 61 INVESTMENT MANAGEMENT 61 WEEK HIGH RECENTLY ECLIPSED 61 SCHEDULE FOR 61 BIODIESEL 61 WHAT YOU CAN 61 THE DIVERSIFIED REITS INDUSTRY 61 HOLDINGS LIMITED 61 PROPOSAL FOR 61 GlaxoSmithKline plc ADR 61 HONOUR FOR 61 CLOSE IN 61 PATIENTS WHO 61 GRIP ON 61 STOCK FALLS 61 WILL NEED 61 Sinclair Pharma 61 Aventis SNY 61 HOLDINGS INC 61 NASDAQ AEZS 61 NORTHERN ROCK 61 BECKHAM 'S 61 WISHES TO 61 RELUCTANT TO 61 HOUSE PRICES 61 THE PREVIOUS 61 TO REVEAL 61 TO PRESENT AT 61 AUST 'S 61 INDIA LTD 61 PRICE FOR 61 Allos Therapeutics ALTH 61 TO GRAB 61 WILL GIVE 61 WEIGHS 61 BIOTECH 61 CHELSEA TARGET 61 GLORY FOR 61 TERM IMPACT 61 SLUMP IN 61 TARGET PRICE 61 PRESSURE ON 61 RETAINING 61 MAY STILL 61 HAS THE SMALLEST 61 RETAINS 61 KLUIVERT 61 UNIT TO 61 PLC ORD 61 DETECTS BEARISH HARAMI PATTERN 61 NOVN 61 ON THE FOLLOWING 61 BREAKS THROUGH SUPPORT 61 WORLD CUP BID 61 LAUNCHED IN 61 FACTS ABOUT 61 PREPARED FOR 61 NOD FOR 61 ARRIVES AT 61 AWARDS FOR 61 IN DARK OVER 61 COMMENCES 61 HIGHEST DEBT TO 61 BULLISH ON 61 TO PUBLISH 61 'S CURRENT 61 TITLE RACE 61 H#N# VACCINE 61 DIALOGUE WITH 61 GLOBAL FINANCIAL 61 WHAT IS HAPPENING 61 THREATENS 61 ADDRESS AT 61 ADVANCES IN 61 FINANCIAL MARKETS 61 SKP.L 61 URGED TO 61 CHARLES SCHWAB 61 FOR NON 61 TECHNOLOGY INC 61 IN FAVOR OF 61 CALLS TO 61 TO SPEND 61 PharmaVitae Profile 61 WATSON PHARMACEUTICALS 61 INVITATION TO THE 61 WITHDRAWAL OF 61 AN INTERVIEW WITH 61 EUROPEAN COMMISSION 61 EARNINGS * 61 COUNTRYWIDE 61 3RD QUARTER 61 AFTER POSTING 61 Plethora Solutions Holdings 61 ZLATAN 61 DATES FOR 61 Keywords FRANCE 61 PUBLIC OFFERING OF 61 SIGNING LOW OF 61 Idenix Pharmaceuticals IDIX 61 BAIRNS 61 QUINS 61 IS LOOKING 61 SLAMMED FOR 61 ROCKED BY 61 EVRA 61 AUDIO PROVIDED BY 61 MUTU 61 JOY FOR 61 LOAN TO 61 APOLOGISES TO 61 SASY.PA 61 CAPITAL CORP 61 ADVISERS 61 BLOW FOR 61 MARRIAGE OF 61 COULD LEAVE 61 ON AREA ROADWAYS 61 LINES UP 61 MAY LEAVE 61 INTERACTIVE BROKERS 61 SIGN UP TO 61 LAW ENFORCEMENT AGENCIES 61 PLUNGED 61 CONNECTION TO 61 TOO LITTLE 61 VAN DER SAR 61 STOLEN FROM 61 WITHDRAWS FROM 61 PROSTATE 61 DERAIL 61 NGSX 61 Oxford BioTherapeutics 61 7 DAYS AGO 61 BUY OUT 61 #-MILLION [001] 61 ALLIED IRISH BANKS 61 ON TUESDAY AND 61 AND MARKETS 61 OLD MUTUAL 61 HOULLIER 61 TO EXTEND 61 DROPS TO 61 SLEW OF 61 PHARMACEUTICALS INC 61 ETO'O 61 ASSAY 61 EPS ESTIMATES FOR 61 FOR CUSTOMERS 61 LIBERTY MUTUAL 61 AMERICAN CAPITAL 61 HIT BACK AT 61 FOR SUNDAY 61 ONLINE PHARMACY 61 INTEREST IN THE 61 POULTER 61 BUYERS ACCUMULATE SHARES OF 61 PHILIP MORRIS 61 GlaxoSmithKline GSK.L 行情 61 Forest Labs FRX 61 WE DESERVE 61 SET TO POSSIBLY REBOUND 61 SPENDING ON 61 FIRED UP FOR 61 CF INDUSTRIES 61 INDUSTRY WITH 61 FIGHT TO 61 QUESTIONS ABOUT 61 REPORTS FIRST QUARTER 61 TO WITHDRAW 61 NASDAQ SHPGY 61 BANKING SECTOR 61 REGAINS 61 BG GROUP 61 WORRIED BY 61 KOUMAS 61 ECONOMIC RECOVERY 61 #.T EXTENDS 61 EXCHANGE OFFER 61 TUMOR 61 FINE FOR 61 ECONOMY AND 61 BRITISH GAS 61 DUO SET 61 FALLS BELOW 3 61 ON THE BRINK 61 #mg Tablets [002] 61 Altana AAA 61 UPBEAT ON 61 INCLUDING CONTACT DETAILS 61 BIELEFELD 61 Keywords GREECE 61 Prana Biotechnology Ltd. 61 REPORTEDLY 61 MULTIPLE MYELOMA 61 INTERIM RESULTS 61 Immupharma 61 RULES FOR 61 PLAYS DOWN 61 TO RAISE 61 WILL BE REPORTED IN 61 THE MOVE LOWER 61 WARNED OVER 61 RUDDOCK 61 IG HCR ;) CO 61 DUE IN 61 LAGGING 61 PRESENTED WITH 61 EXAMINES 61 INVESTMENT BANKING 61 CREATION OF 61 FORWARD TO 61 UNIT OF 61 ABANDONS 61 MOVING AVERAGE CROSSOVER ALERT 61 Vernalis Plc 61 REED ELSEVIER 61 DEFEAT FOR 61 QUANTITATIVE 61 BREAKS THROUGH RESISTANCE AT 61 FACES NEW 61 LORILLARD 61 SENTENCED TO LIFE 61 EMIR RECEIVES 61 EXPORTS TO 61 FLML 61 WITH LITTLE 61 DILEMMA FOR 61 TOP TWO 61 HIT BACK 61 MBRK 61 PRIVATISATION 61 DIALOGUE ON 61 SEEKS NEW 61 SCHLUMBERGER 61 GROUP SAYS 61 TARGET OF 61 TO REMAIN 61 RESTORATION OF 61 SHARE ISSUE 61 RANDGOLD RESOURCES 61 TO MAINTAIN 61 ADMISSION TO 61 EXTENT OF 61 HIGHER PRICES ON 1X 61 GEARS UP FOR 61 AS LOW 61 FOR SCOTLAND 61 SUNK BY 61 SHARES OF ARE MOVING 61 TO SATISFY 61 ENTERED INTO 61 Protherics PLC

Back to home page